Drug & intervention
hepatitis A virus strain CR 326F antigen, inactivated Injection [Vaqta]
RxCUI 2275276
What this record represents
SBDF · RxNormThis is an RxNorm SBDF drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
VaqtaBN · CureCurrent ID 21953
hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML [Vaqta]SBDC · CureCurrent ID 70272
hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe [Vaqta]SBDF · CureCurrent ID 70275
1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta]SBD · CureCurrent ID 60179
0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta]SBD · CureCurrent ID 60181
1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta]SBD · CureCurrent ID 41018
0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta]SBD · CureCurrent ID 41020
Advertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.